Literature DB >> 9534673

Kawasaki disease in Australia, 1993-95.

J A Royle1, K Williams, E Elliott, G Sholler, T Nolan, R Allen, D Isaacs.   

Abstract

AIM: To describe the epidemiology, management, and rate of cardiac sequelae of Kawasaki disease in Australia.
DESIGN: Cases were notified to the Australian Paediatric Surveillance Unit, an active national surveillance scheme, from May 1993 to June 1995.
RESULTS: 139 cases of Kawasaki disease were confirmed. In 1994, the annual incidence was 3.7/100,000 children < 5 years old. Sixteen children were not admitted to hospital. Coronary artery abnormalities were reported in 35 (25%) children. Two patients were diagnosed at postmortem examination. Sixty six per cent of patients were diagnosed within 10 days of onset and 81% of these received intravenous gammaglobulin within 10 days. Forty five of the notified children did not fulfil the study criteria because of streptococcal infection or insufficient clinical criteria. One child with streptococcal infection had coronary artery dilatation.
CONCLUSION: Diagnosis of Kawasaki disease was delayed beyond 10 days in one third of patients, and almost 20% of children who could have received gammaglobulin within 10 days did not. The distinction between Kawasaki disease, streptococcal infection, and other possible diagnoses is problematic in some children.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9534673      PMCID: PMC1717439          DOI: 10.1136/adc.78.1.33

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  28 in total

Review 1.  Current therapy for acute Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  J Pediatr       Date:  1991-06       Impact factor: 4.406

2.  High-dose gammaglobulin therapy for Kawasaki disease.

Authors:  M Nagashima; M Matsushima; H Matsuoka; A Ogawa; N Okumura
Journal:  J Pediatr       Date:  1987-05       Impact factor: 4.406

3.  Kawasaki disease in Auckland, 1979-1988.

Authors:  T L Gentles; P M Clarkson; A A Trenholme; D R Lennon; J M Neutze
Journal:  N Z Med J       Date:  1990-08-22

4.  Overlap between Kawasaki disease and group A streptococcal infection.

Authors:  S Hoare; M Abinun; A J Cant
Journal:  Pediatr Infect Dis J       Date:  1997-06       Impact factor: 2.129

Review 5.  What is the status of intravenous gamma-globulin for Kawasaki syndrome in the United States and Canada?

Authors:  A H Rowley; S T Shulman
Journal:  Pediatr Infect Dis J       Date:  1988-07       Impact factor: 2.129

6.  Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group.

Authors:  J C Burns; W H Mason; M P Glode; S T Shulman; M E Melish; C Meissner; J Bastian; A S Beiser; H M Meyerson; J W Newburger
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

7.  A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.

Authors:  J W Newburger; M Takahashi; A S Beiser; J C Burns; J Bastian; K J Chung; S D Colan; C E Duffy; D R Fulton; M P Glode
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

Review 8.  Kawasaki syndrome.

Authors:  A H Rowley; F Gonzalez-Crussi; S T Shulman
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

Review 9.  Probable role of Streptococcus pyogenes in Kawasaki disease.

Authors:  T Akiyama; K Yashiro
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

Review 10.  Gallbladder hydrops in mucocutaneous lymph node syndrome.

Authors:  Y S Choi; B Sharma
Journal:  South Med J       Date:  1989-03       Impact factor: 0.954

View more
  22 in total

1.  Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care.

Authors:  L Appleby; G Koren; D Sharp
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

2.  Kawasaki disease--a diagnostic challenge.

Authors:  A Harnden
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

3.  Evaluation of a national surveillance unit.

Authors:  M Gazarian; K Williams; E Elliott; K Chant; H Longbottom; C Mellis; T Nolan; R K Oates; A Ruben
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

4.  Rising incidence of Kawasaki disease in England: analysis of hospital admission data.

Authors:  Anthony Harnden; Bernadette Alves; Aziz Sheikh
Journal:  BMJ       Date:  2002-06-15

Review 5.  Kawasaki disease in the adult: a case report and review of the literature.

Authors:  Juan Carlos Rozo; John L Jefferies; Benjamin W Eidem; Patrick J Cook
Journal:  Tex Heart Inst J       Date:  2004

Review 6.  Non-infectious makers of Kawasaki syndrome: tangible or elusive triggers?

Authors:  Donato Rigante; Giusyda Tarantino; Piero Valentini
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

7.  Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.

Authors:  Jane C Burns; Chisato Shimizu; Enrique Gonzalez; Hemant Kulkarni; Sukeshi Patel; Hiroko Shike; Robert S Sundel; Jane W Newburger; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2005-06-08       Impact factor: 5.226

8.  Rare disease surveillance: An international perspective.

Authors:  E J Elliott; A Nicoll; R Lynn; V Marchessault; R Hirasing; G Ridley
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

9.  Acute severe hepatitis with coagulopathy: An unusual presentation of Kawasaki syndrome in association with Epstein-Barr virus.

Authors:  M M Gordon; E D Silverman; J H Kim; A M Huber; K Furuya
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

10.  Incomplete, atypical kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report.

Authors:  Shakeel Shaikh; Sidra Ishaque; Taimur Saleem
Journal:  Cases J       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.